Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/BIO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

BIO trades at $296.11, down 0.39% today, with a bullish technical outlook supported by moving averages and a consensus price target of $305. The company reported $2.58B revenue in 2025 with net income of $759.90M, showing a significant turnaround from prior losses. Recent news highlights Nasdaq compliance restoration and participation in industry events, reinforcing operational stability.
BIO presents a positive investment case with strong analyst support (53.85% buy ratings) and improving profitability, though high P/E of 49.27 and recent earnings misses pose valuation and execution risks. Upside potential exists if the company meets future earnings expectations, but investors should monitor debt levels and competitive pressures in the biotech sector.
Read full analysis

Key Stats

  • Market Cap
    $7.94B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $339.75
  • 52W Low
    $241.71
  • Typical Hold Time
    -
  • Enterprise Value
    $7.75B
  • Div Yield
    -
  • Trading Activity
    -
$297.03
52W Low: $241.71
12 May 2026
52W High: $339.75
24 Oct 2025

Track Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $241.71 and a high of $339.75, highlighting its annual price range. Buy and sell Bio-Rad Laboratories, Inc. Class A Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Most Recent News

Content is generated by Aura AI

AI use in cybersecurity jumps to 78% in 2026, but governance and failures lag behind.

The 2026 SANS AI Survey reveals rapid AI adoption in cybersecurity, with 78% of organizations using AI, up from 50% last year. However, governance structures and formal audit frameworks have not kept pace, leading to increased AI-related failures in ...

Market News
1 hour ago
Matt Bromiley
Neutral
pluang ai news

Head and neck squamous cell carcinoma market to grow 10.5% CAGR through 2036 with new immunotherapies.

The head and neck squamous cell carcinoma (HNSCC) market is projected to grow at a 10.5% CAGR from 2026 to 2036, driven by rising cancer incidence and new immunotherapy launches. Key emerging therapies from companies like Johnson & Johnson, BioNTech,...

Market News
3 hours ago
Na
Bullish
news icon
pluang ai news

Alamar Biosciences launches national study analyzing 21,000 plasma samples to advance Alzheimer's biomarkers.

Alamar Biosciences has partnered with top U.S. research universities to start a nationwide proteomics project using its NULISAseq™ Neuro 220 panel. The study will analyze about 21,000 plasma samples from 10,000 Alzheimer's and related dementia partic...

Market News
3 hours ago
Na
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $7.94B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $339.75
  • 52W Low
    $241.71
  • Typical Hold Time
    -
  • Enterprise Value
    $7.75B
  • Div Yield
    -
  • Trading Activity
    -
$297.03
52W Low: $241.71
12 May 2026
52W High: $339.75
24 Oct 2025

Track Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $241.71 and a high of $339.75, highlighting its annual price range. Buy and sell Bio-Rad Laboratories, Inc. Class A Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!